Dr. Tatjana Kolevska, MD
- Part D claims, 2024
- 130
- Publications
- 43
- Clinical trials
- 16
- Hospital affiliations
- 1
- Medical group
- 1
- Practice address
- 975 Sereno Dr, Vallejo, CA 94589
- Practice phone
- Call (707) 651-1000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Kolevska's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Tatjana Kolevska is a hematologist and oncologist in Vallejo, California
Dr. Kolevska practices at Vallejo Medical Center in Vallejo, California, part of Kaiser Permanente.
Dr. Kolevska's NPI, 1760554596, was assigned on November 15, 2006. Dr. Kolevska graduated from University of Zagreb Faculty of Medicine in 1986. Dr. Kolevska holds California license A79150.
- NPI
- 1760554596NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7517958077
- NPI enumeration date
- November 15, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (707) 651-1000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Tatjana Kolevska practices at Vallejo Medical Center in Vallejo, California
Dr. Kolevska's primary practice is Vallejo Medical Center, at 975 Sereno Dr, Vallejo, CA 94589 in Solano County. The practice phone is (707) 651-1000.
- Vallejo Medical Center975 Sereno Dr, Vallejo, CA 94589 · Solano CountyPhone(707) 651-1000
Source: Dmand AI Affiliation Data
Dr. Tatjana Kolevska is affiliated with 3 sites of care and 1 medical group
Dr. Kolevska's primary practice is Vallejo Medical Center in Vallejo, California, part of Kaiser Permanente. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Kolevska to 1 more home health agency and 1 hospice, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Tatjana Kolevska's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolevska practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Vallejo Medical Center | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kaiser Permanente and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Tatjana Kolevska is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Kolevska's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kolevska is board certified in medical oncology by the American Board of Internal Medicine. Dr. Kolevska is licensed in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Hematologists and oncologists near Dr. Kolevska
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Tatjana Kolevska's patients have a median age of 45
Across all payers, Dmand AI patient panel data puts Dr. Kolevska's median patient age at 45, with 56% women.
Dr. Kolevska's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 45
Patient panel by sex, all payers
- Women56%
- Men44%
Source: Dmand AI Patient Panel Data
Dr. Tatjana Kolevska wrote 130 Medicare Part D claims in 2024
In 2024, Dr. Kolevska wrote 130 Medicare Part D claims for 38 patients. 72% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $385,171 in total drug cost. In 2023, CMS named 64 claims across 5 drugs.
Dr. Kolevska's Part D claims by kind of drug, 2024
- Generic94 claims72%
- Brand-name36 claims28%
Dr. Kolevska's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 642024: 4234%
Drugs named by CMS: 3 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Tatjana Kolevska takes part in Medicare
Dr. Kolevska accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Tatjana Kolevska has 43 publications on record
Dmand AI links 43 papers to Dr. Kolevska, published from 2010 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and COVID-19. Dr. Kolevska has published most often in JCO Clin Cancer Inform. Dr. Kolevska's most frequent co-authors are Raymond W. Liu, MD, Raymond Liu, MD and Jennifer Jane Griggs, MD, MPH.
Dr. Kolevska's papers by year, 2014 to 2025
Topics Dr. Kolevska writes about most
- Breast Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- COVID-19
- Telemedicine
- Caregivers
- Pandemics
- Delivery of Health Care, Integrated
- Medical Oncology
Dr. Kolevska's most frequent co-authors
- Raymond W. Liu, MD14 shared papers
- Raymond Liu, MD9 shared papers
- Jennifer Jane Griggs, MD, MPH8 shared papers
Recent publications by Dr. Kolevska
JCO Clin Cancer Inform
Breast Cancer Res Treat
See who Dr. Kolevska researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kolevska works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Tatjana Kolevska has worked on 16 clinical trials
Dmand AI links Dr. Kolevska to 16 clinical trials, 9 of them phase 3 studies. 14 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Anal Canal Carcinoma. National Cancer Institute (NCI) sponsors the most, 11.
Clinical trials with Dr. Kolevska by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 2Phase 2/3: 2 trials
- 9Phase 3: 9 trials
- NonePhase 4: no trials
Conditions in Dr. Kolevska's trials
- Melanoma
- Nevi and Melanomas
- Anal Canal Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Leukemia, Lymphocytic, Chronic, B-Cell
Investigators on the most trials with Dr. Kolevska
- Preston D. Steen, MD6 shared trials
- Willard Guy Andrews, MD5 shared trials
- Steven Alan Akman, MD4 shared trials
Recent clinical trials with Dr. Kolevska
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel (opens in a new tab)
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients (opens in a new tab)
A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma (opens in a new tab)
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Tatjana Kolevska has 1 award and honors on record
Dmand AI lists 1 award for Dr. Kolevska, most recently CMS Stage 1 2012 in 2011.
Awards and honors for Dr. Kolevska
- 2011
- CMS Stage 1 2012
Source: Dmand AI Professional Profile Data
Dr. Tatjana Kolevska graduated from University of Zagreb Faculty of Medicine
Dr. Kolevska graduated from University of Zagreb Faculty of Medicine in 1986. Dr. Kolevska is a member of ASCO.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Tatjana Kolevska accepts plans from 2 insurance carriers
Dr. Kolevska is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Kolevska accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Tatjana Kolevska's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Tatjana Kolevska
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Tatjana Kolevska's NPI number?
Dr. Tatjana Kolevska's NPI number is 1760554596. It was assigned on November 15, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Tatjana Kolevska?
Dr. Tatjana Kolevska is a hematologist and oncologist in Vallejo, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Tatjana Kolevska practice?
Dr. Kolevska practices at 975 Sereno Dr, Vallejo, CA 94589. Dr. Kolevska's primary practice is Vallejo Medical Center in Vallejo, California, part of Kaiser Permanente. Dmand AI also links Dr. Kolevska to 1 home health agency and 1 hospice.
What is Dr. Tatjana Kolevska's office phone number?
The practice phone on file for Dr. Kolevska is (707) 651-1000.
What is Dr. Tatjana Kolevska's medical license number?
Dr. Kolevska holds California license A79150.
Which hospitals is Dr. Tatjana Kolevska affiliated with?
Dr. Kolevska practices at Vallejo Medical Center in Vallejo, California.
What medical group is Dr. Tatjana Kolevska part of?
Dr. Kolevska is linked to The Permanente Medical Group, Inc.
Does Dr. Tatjana Kolevska accept Medicare?
Yes. CMS lists Dr. Kolevska as accepting Medicare assignment.
Is Dr. Tatjana Kolevska board certified?
Yes. Dr. Kolevska is board certified in medical oncology by the American Board of Internal Medicine.
Where did Dr. Tatjana Kolevska go to medical school?
Dr. Kolevska graduated from University of Zagreb Faculty of Medicine in 1986.
Show 5 more questionsShow fewer questions
What drugs does Dr. Tatjana Kolevska prescribe most?
In 2024 Medicare Part D data, Dr. Kolevska's most prescribed drugs by claims were Lenalidomide, Anastrozole and Tagrisso.
How long has Dr. Tatjana Kolevska been practicing?
Dr. Kolevska graduated from medical school in 1986, 40 years ago.
Does Dr. Tatjana Kolevska do research?
Dmand AI links 43 publications to Dr. Kolevska, published from 2010 to 2025. Dr. Kolevska has worked on 16 clinical trials.
Who does Dr. Tatjana Kolevska publish with?
Dr. Kolevska's most frequent co-authors are Raymond W. Liu, MD (14 shared papers), Raymond Liu, MD (9 shared papers) and Jennifer Jane Griggs, MD, MPH (8 shared papers).
What insurance does Dr. Tatjana Kolevska accept?
Dr. Kolevska is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card